|
|
|
Press Release: Fifth Asia Pac Pharma Compliance Congress Features Ashley Watson, Esq., SVP, Chief Ethics and Compliance Officer, Merck Sharp and Dohme
|
- A Hybrid Conference and Internet Event
- Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Pharmaceutical Compliance Forum (PCF), Pharmaceutical and Healthcare Association of the Philippines (PHAP) and Philippine Alliance of Patient Organizations (PAPO)
- Offered in Sequence with the APEC 2nd Business Ethics for Small & Medium Size Enterprises (SME) Forum (August 19 - 20, 2015)
- August 17 - 18, 2015
- Sofitel Philippine Plaza
- Manila, Philippines
- www.AsianPharmaCongress.com
PRESS RELEASE
Phone: 800-503-6498
Email: registration@hcconferences.com
Website: www.AsianPharmaCongress.com
EARLY BIRD REGISTRATION EXTENDED
- SAVE UP TO $600 -
|
Register by Friday, July 10, 2015 for Early Bird discount. Save up to $600.
Click here to register.
|
|
|
OFFERED IN SEQUENCE WITH
|
APEC 2nd Business Ethics for Small & Medium Size Enterprises (SME) Forum
August 19 - 20, 2015
www.MCPrinciples.org
|
|
|
FEATURING A GLOBAL CHIEF COMPLIANCE OFFICER'S PERSPECTIVE BY
|
 |
Ashley Watson, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Merck Sharp and Dohme, Former Counsel, Chief Ethics and Compliance Officer, Hewlett-Packard, Philadelphia, PA, USA
|
|
|
|
MANILA, PHILIPPINES -- PHARMA UPDATE NEWS SERVICE™ -- JULY 7, 2015: The Fifth Asia Pacific Pharmaceutical Compliance Congress, www.AsianPharmaCongress.com, will be held August 17 - 18, 2015, in Manila, Philippines at the Sofitel Philippine Plaza. Registrants may attend the event in person or online (live webcast and archived for 6 months).
|
CO CHAIRS
|
Masood Ahmed
Vice President, Regional Compliance Officer Asia & JPAC, Sanofi Group, Singapore |
Karen Eryou
Senior Director, Corporate Compliance APAC, UCB Pharma, Shanghai, China
|
Maria "Maru" Quindimil, MBA
Executive Director, People Development, Business Practices Compliance and Risk Management Division, APAC Region, Pharsight, Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Manila, Philippines |
Rhys Tee
Compliance Director, Asia, Abbott Laboratories (Singapore) Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore
|
|
|
KEYNOTE SPEAKERS
|
Robert Barrington, PhD
(via video)
Executive Director, Transparency International-UK, London, UK |
Jean-Luc Lowinski, PhD
Senior Vice President, Asia Region, Sanofi, President, Sanofi China, Former Head, Bayer Healthcare, Asia Pacific, Shanghai, China |
Theresa Martinez, MBA
General Manager, Roche Philippines, Inc., Manila, Philippines
|
Beaver R. Tamesis, MD
President and Managing Director, MSD in the Philippines, Manila, Philippines |
Ashley Watson, Esq.
Senior Vice President, Chief Ethics & Compliance Officer, Merck Sharp and Dohme, Former Counsel, Chief Ethics and Compliance Officer, Hewlett-Packard, Philadelphia, PA, USA
|
|
|
PHILIPPINE KEYNOTE SPEAKERS
|
Karen Alparce-Villanueva
Consultant, Philippine Alliance of Patient Organizations, Manila, Philippines |
Dra Minerva Calimag, MD
President, Philippine Medical Association, Manila, Philippines |
Fatima "Girlie" Garcia-Lorenzo
Executive Director, Philippine Alliance of Patient Organizations, Manila, Philippines
|
Reiner Gloor
President, Birgli AG, Advisor, Pharmaceutical & Healthcare Association of the Philippines, Former Executive Director, Pharmaceutical & Healthcare Association of the Philippines, Former Chairman, Buergli Pharma Inc., Manila, Philippines |
Cynthia K. Magdaraog
President of Philippine Society of Orphan Disorders, Manila, Philippines |
Ramonito Tampos
President and Managing Director, Merck Philippines, Manila, Philippines
|
|
|
OFFERED IN SEQUENCE WITH
|
APEC 2nd Business Ethics for Small & Medium Size Enterprises (SME) Forum
August 19 - 20, 2015
Including its pharma working group re APEC Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector, known as the "Mexico City Principles", and the medical device working group re the Nanjing Declaration to Promote Ethical Business Practices in the Medical Device and Biopharmaceutical Sectors (2014-2020), known as the "Nanjing Declaration".
For more information go
to www.MCPrinciples.org.
|
|
|
ROUNDTABLE ON HOT ASIA PAC PHARMA AND DEVICE COMPLIANCE ISSUES
|
Campbell Clark
General Counsel, Asia, Covidien, Singapore |
Katsumi Kojima
Corporate Officer, Country Compliance Officer Japan, Sanofi, Former Director, Regional Compliance Officer APAC/JAPAN, Edwards Lifesciences, Tokyo, Japan |
Cristopher Landrito, LIB
Regional Compliance Officer, APAC Group Compliance, Merck Pte. Ltd., Singapore
|
Redentor Romero, JD
Regional Compliance Officer, Teva Pharmaceuticals, Former Regional Legal Counsel - Southeast Asia & Taiwan, AstraZeneca Pharmaceuticals, Singapore |
Sandeep Seth
Director - Compliance, Merck & Co., Mumbai, India |
Clarissa Shen
Country Compliance Officer, Sanofi China, Former Associate Compliance, Director, Eli Lilly China, Shanghai, China
|
|
|
GLOBAL ANTICORRUPTION UPDATE
|
Ted Acosta, Esq.
Americas Vice Chair, Risk Management and Global Leader, Life Sciences, Fraud Investigation and Dispute Services, EY, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France (Moderator) |
Donemark Calimon, LLB
Partner, Quisumbing Torres, A member firm of Baker & McKenzie International, Manila, Philippines |
Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC, USA
|
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief, Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA |
Chen Yang, Esq.
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China
|
|
|
GLOBAL TRANSPARENCY UPDATE
|
|
Global Transparency Update
|
Diva DUONG
Vice President Compliance EMEA-APAC, IMS Health, Paris, France
|
|
|
Australia Update
|
Andrew Ho
Country Compliance Officer, Australia and New Zealand, Compliance and Business Integrity, Sanofi Group; Former Compliance Associate, Novartis, Macquarie Park, NSW, Australia
|
|
Japan Voluntary Transparency
Guidelines Update
|
Yota Kikuchi
Manager, Compliance Japan, Sanofi Group; Vice Chairman, Code Practices, Committee, Japan Pharmaceutical Manufacturers Association; Member, IFPMA Code, Compliance Network, Tokyo, Japan
|
|
Research and Clinical
Trials Update
|
Jessica Santos, PhD, CIPP/E
Global Compliance Director, Kantar Health; Former Vice, President, Methodology and Compliance, WorldOne, Cambridge, UK
|
|
|
|
FEATURED FACULTY
|
Dimas Adityo, MA
Compliance Director, Sanofi, Jakarta Area, Indonesia |
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA |
Maija Burtmanis, LLB, LLM
Founder and Managing Director, Compliance Risk Logic, Former Regional Compliance Director, Asia, Australia, Africa, Middle East & Japan, AbbVie, Singapore
|
Chi Chen
Partner, Forensic Technology and Discovery Services, EY, Shanghai, China |
Eugene Chen, Esq.
Partner, Shanghai Office, Hogan Lovells International LLP, Shanghai, China |
Myung Soon Chung, Esq.
Partner, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea
|
Laurent Clerc
Co-founder and Regulatory Affairs Expert, BMI SYSTEM, Paris, France |
Georgie Farrant, LLB
Partner, Baker & McKenzie, Sydney, Australia |
Mohit Grover
Executive Director, Risk Consulting, Deloitte; a leader in the Life Science and Health Care Industry in Southeast Asia; Former Regional CIO, Astra Zeneca Asia Pacific, Singapore
|
Divina Ilas-Panganiban, LLM
Partner, Quisumbing Torres, A member firm of Baker & McKenzie International, Manila, Philippines |
Marjotin Javellana
Director, Business Excellence & Alliance Management, Merck Sharp and Dohme (Asia Ltd.), Manila, Philippines |
Angela Mancini
Director of Global Client Services, Southeast Asia, Control Risks
|
Maria Christina J. Macasaet-Acaban, LLB
Partner and Head, Pharmaceuticals & Healthcare Industry Group, Philippines, Member, Asia Pacific Pharmaceuticals & Healthcare Steering Committee, Baker & McKenzie, Manila, Philippines |
Andrew Martin, SFE
Partner and Head, Corporate & Securities Practice Group in Singapore, Member, Global Compliance Steering Committee, Baker & McKenzie/Wong & Leow, Singapore |
Chrisoula Nikidis
Director, Ethics and Compliance, Canada's Research-Based Pharmaceutical Companies (Rx&D), Ottawa, ON, Canada
|
Paul Peterson, CPA, CIA, CFE
Director, Grant Thornton China, Shanghai, China |
Yee Chung Seck, LLB
Partner, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam |
Sabina Sudan, LLB, LLM
Senior Global Legal/Compliance & Risk Management Professional, Former Vice President and Compliance Officer- EJEMAP, GSK, Former Director- Compliance APAC, Abbott, Delhi, India
|
Belinda Tan
Partner, Fraud Investigation & Dispute Services, EY, Singapore |
Roderick T. Vega
Partner, Fraud Investigation and Dispute Services, EY, Manila, Philippines |
Emmanuel Vignal
Greater China Leader, Fraud Investigation & Dispute Services, EY, Shanghai, China
|
Wimbanu Widyatmoko, LLM
Partner, Hadiputranto, Hadinoto & Partners, A member firm of Baker & McKenzie International, Jakarta, Indonesia |
Russell Williams
President, Canada's Research-Based Pharmaceutical Companies (Rx&D), Former Member, National Assembly of Quebec, Ottawa, ON, Canada |
Michael Woodward
General Manager, Asia Pacific Region, The Red Flag Group, Hong Kong
|
|
|
|
|
|
SPECIAL ASIA PACIFIC HEALTHCARE INDUSTRY COMPLIANCE TEAM / PHAP / PAPO / APEC / ETHICS / IFPMA / PCF INDIVIDUAL RATE
|
Click here for special rates.
|
|
|
|
BROCHURE NOW AVAILABLE
|
Click here to download the brochure.
|
|
COSPONSORED BY:
|
The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
The Pharmaceutical and Healthcare Association of the Philippines (PHAP) and it's 56 member companies represent the research -based and pharmaceutical and healthcare industry, a key sector in the never ending fight for improved health through the continuous development of new , better, more efficacious and cost-effective drug therapies.
The Philippine Alliance of Patient Organizations (PAPO) is the umbrella organization of all the patient groups in the Philippines. It is an affiliate of the International Alliance of Patient Organizations.
The Philippine Medical Association is the primary medical association of the Philippines, covering medical practitioners and component medical groups from the entire country. It is a member of the World Medical Association and is a co-founder of the Confederation of Medical Associations of Asia and Oceania. It is also the co-founder of Medical Associations of South East Asian Nations.
|
|
GRANTORS:
|
|
BRONZE
|
|
|
MEDIA PARTNER
|
|
|
TOPICS TO BE COVERED
|
- Training on Compliance and Ethics Basics
- Hot Asia Pac Compliance Issues Roundtable
- Philippine Pharmaceutical and Medical Associations and Government Roundtable
- Philippine Alliance of Patient Organizations Roundtable
- Compliance and Ethics: Tone from the Top and Middle
- A Global Chief Compliance OfficerÂ’s Perspective
- Global Compliance Code and APEC Principles Updates
- Global Anticorruption 2.0 Update
- Transparency InternationalÂ’s new Pharma Industry Initiative
- Global Transparency/Disclosure Update
- Managing and Monitoring Mature Third Party Relationships
- Risk Management for Compliance and Business
- Medical Device Compliance Roundtable
- Ethical Interactions with Patients
- China Compliance Roundtable
- Southeast Asia Compliance Roundtable
- Responding to Investigations
- Compliance Analytics Roundtable
- Travel, Entertainment, Service Agreements and Honoraria
- Samples, Grants, Donations and Social Media
- Compliance Issues in M&A
|
|
CONTINUING EDUCATION CREDITS
|
- Accounting Professionals: Approved for up to 14 NASBE CPE credits.
- Compliance Professionals: The Congress is currently pending approval to offer Compliance Certification Board CCB Credits.
- Attorneys: The Congress is currently pending approval to offer California and Pennsylvania MCLE Credit.
Click here for more information.
|
|
SAVE THE DATE
|
Mastering Compliance in International Markets
June 8 - 9, 2015 in Singapore
Click here for info.
|
|
OTHER PHARMA CONGRESS CITIES
|
2007 - Brussels, Belgium
2008 - Paris, France
2009 - Rome, Italy
2010 - Berlin, Germany
2011 - Singapore
2012 - Shanghai, China
2013 - Kuala Lumpur, Malaysia
2014 - Dubai, United Arab Emirates
2014 - Mexico City, Mexico
|
|
|
|
|
|
